Atle Fund Management AB

Position in DXCM — Dexcom Inc

CIK 1381843 STOCKHOLM, V7

Position in DXCM

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$4,838,828

+$2,198,905 QoQ

Shares Held

71,846

-87.7% QoQ

Ownership

0.019%

of shares outstanding

% of Portfolio

1.30%

of 13F equity value

Holder Rank

#275

of 966 holders

Holding Since

Dec 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Atle Fund Management AB holds $36,394,285 across 5 Medical Devices names. DXCM ranks #5 (13.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SYK	Stryker Corp	30,283	$9,534,299
2	EW	Edwards Lifesciences Corp	103,230	$9,338,185
3	IRTC	iRhythm Holdings, Inc.	54,102	$6,435,432
4	BSX	Boston Scientific Corp	146,381	$6,247,541
5	DXCM	Dexcom Inc This page	71,846	$4,838,828

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,838,828	71,846	-87.7%	Shares	Sole	2026-07-24
2026-03-31	$2,639,923	584,332	+1371.1%	Shares	Sole	2026-05-11
2025-12-31	$2,636,349	39,722	-21.9%	Shares	Sole	2026-02-06
2025-09-30	$363,418	50,872	0.0%	Shares	Sole	2025-11-04
2025-06-30	$4,440,616	50,872	+11.0%	Shares	Sole	2025-07-14
2025-03-31	$3,130,481	45,841	-23.7%	Shares	Sole	2025-05-05
2024-12-31	$4,670,632	60,057	+11.7%	Shares	Sole	2025-02-04
2024-09-30	$3,603,869	53,757	+55.9%	Shares	Sole	2024-11-12
2024-06-30	$3,909,682	34,483	+31.2%	Shares	Sole	2024-08-14
2024-03-31	$3,645,452	26,283	+45.6%	Shares	Sole	2024-04-25
2023-12-31	$2,240,693	18,057	+5939.1%	Shares	Sole	2024-01-30
2022-12-31	$33,858	299	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.